Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review.

MLA

Mateus, Tiago, et al. “Outcome Measures Frequently Used to Assess Muscle Strength in Patients with Myotonic Dystrophy Type 1: A Systematic Review.” Neuromuscular Disorders : NMD, vol. 32, no. 2, Feb. 2022, pp. 99–115. EBSCOhost, https://doi.org/10.1016/j.nmd.2021.09.014.

APA

Mateus, T., Costa, A., Viegas, D., Marques, A., Herdeiro, M. T., & Rebelo, S. (2022). Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review. Neuromuscular Disorders : NMD, 32(2), 99–115. https://doi.org/10.1016/j.nmd.2021.09.014

Chicago

Mateus, Tiago, Adriana Costa, Diana Viegas, Alda Marques, Maria Teresa Herdeiro, and Sandra Rebelo. 2022. “Outcome Measures Frequently Used to Assess Muscle Strength in Patients with Myotonic Dystrophy Type 1: A Systematic Review.” Neuromuscular Disorders : NMD 32 (2): 99–115. doi:10.1016/j.nmd.2021.09.014.